A choice of radionuclide: Comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma

Both 125I and 106Ru eye plaque brachytherapy treatment result in encouraging tumor control for patients with uveal melanoma. We demonstrate that 106Ru offers these benefits with reduced toxicity in patients treated for uveal melanomas ≤ 5 mm in apical height.